Vivani Medical VANI
NASDAQ VANI
$1.11 -0.01 (-1.18%)
As of: Nov 10, 2026 · 2:22 PM EST

Vivani Medical (VANI) Cash from Restructuring (2019 - 2020)

Updated

Analysis

Vivani Medical (VANI) Cash from Restructuring (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Vivani Medical 97.98 Mn 39.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 98,000.00
Sep 30, 2020 1,000.00
Mar 31, 2020 1.12 Mn
Jun 30, 2019 163,000.00
Mar 31, 2019 2.42 Mn
API Access

Vivani Medical Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=VANI&period=max&api_key=YOUR_API_KEY